<?xml version="1.0" encoding="UTF-8"?>
<evalitem filename="/home/alesch/workbench/workspace-nepomuk/KeywordExtractionPubMedEvaluation/resources/corpus/Arch_Dermatol_Res/Arch_Dermatol_Res-_-_-1461773.nxml" pmcid="1461773">
  <document-statistics>
    <language value="en" />
    <document-size value="4634" />
    <lexicon-size value="796" />
  </document-statistics>
  <metrics>
    <recall value="0.857" />
    <accuracy value="0.120" />
    <precision value="0.120" />
  </metrics>
  <gold-standard>
    <keyphrase term="Long-term treatment" eval-status="C1_SUFFIX" />
    <keyphrase term="Alefacept" eval-status="FULL_MATCH" />
    <keyphrase term="Efalizumab" eval-status="FULL_MATCH" />
    <keyphrase term="Psoriasis" eval-status="FULL_MATCH" />
    <keyphrase term="Infliximab" eval-status="FULL_MATCH" />
    <keyphrase term="Etanercept" eval-status="FULL_MATCH" />
    <keyphrase term="Biological" eval-status="C2_PREFIX" />
  </gold-standard>
  <prediction>
    <keyphrase term="PASI75 response" eval-status="UNMATCHED" />
    <keyphrase term="mg twice weekly" eval-status="UNMATCHED" />
    <keyphrase term="Phase III trials" eval-status="UNMATCHED" />
    <keyphrase term="Phase III study" eval-status="UNMATCHED" />
    <keyphrase term="weeks" eval-status="UNMATCHED" />
    <keyphrase term="long-term studies" eval-status="UNMATCHED" />
    <keyphrase term="safety data" eval-status="UNMATCHED" />
    <keyphrase term="adverse events" eval-status="UNMATCHED" />
    <keyphrase term="psoriasis" eval-status="FULL_MATCH" />
    <keyphrase term="efalizumab" eval-status="FULL_MATCH" />
    <keyphrase term="placebo" eval-status="UNMATCHED" />
    <keyphrase term="moderate" eval-status="UNMATCHED" />
    <keyphrase term="randomized" eval-status="UNMATCHED" />
    <keyphrase term="alefacept" eval-status="FULL_MATCH" />
    <keyphrase term="etanercept" eval-status="FULL_MATCH" />
    <keyphrase term="infliximab" eval-status="FULL_MATCH" />
    <keyphrase term="analysis" eval-status="UNMATCHED" />
    <keyphrase term="efficacy" eval-status="UNMATCHED" />
    <keyphrase term="PASI75" eval-status="UNMATCHED" />
    <keyphrase term="patients" eval-status="UNMATCHED" />
    <keyphrase term="week course" eval-status="UNMATCHED" />
    <keyphrase term="biological therapies" eval-status="C2_PREFIX" />
    <keyphrase term="treatment" eval-status="C1_SUFFIX" />
    <keyphrase term="trials" eval-status="UNMATCHED" />
    <keyphrase term="long-term data" eval-status="UNMATCHED" />
    <keyphrase term="clinical data" eval-status="UNMATCHED" />
    <keyphrase term="data" eval-status="UNMATCHED" />
    <keyphrase term="percentage PASI improvement" eval-status="UNMATCHED" />
    <keyphrase term="initial improvements" eval-status="UNMATCHED" />
    <keyphrase term="safety" eval-status="UNMATCHED" />
    <keyphrase term="biological agents" eval-status="C2_PREFIX" />
    <keyphrase term="initial 12" eval-status="UNMATCHED" />
    <keyphrase term="BSA" eval-status="UNMATCHED" />
    <keyphrase term="months" eval-status="UNMATCHED" />
    <keyphrase term="mg dosage" eval-status="UNMATCHED" />
    <keyphrase term="results" eval-status="UNMATCHED" />
    <keyphrase term="continuous long-term administration" eval-status="UNMATCHED" />
    <keyphrase term="common adverse events" eval-status="UNMATCHED" />
    <keyphrase term="annual meeting" eval-status="UNMATCHED" />
    <keyphrase term="continuous control" eval-status="UNMATCHED" />
    <keyphrase term="long-term administration" eval-status="UNMATCHED" />
    <keyphrase term="Phase II" eval-status="UNMATCHED" />
    <keyphrase term="response" eval-status="UNMATCHED" />
    <keyphrase term="chronic inflammatory" eval-status="UNMATCHED" />
    <keyphrase term="induction" eval-status="UNMATCHED" />
    <keyphrase term="similar" eval-status="UNMATCHED" />
    <keyphrase term="biologicals" eval-status="C2_PREFIX" />
    <keyphrase term="eligible" eval-status="UNMATCHED" />
    <keyphrase term="study" eval-status="UNMATCHED" />
    <keyphrase term="courses" eval-status="UNMATCHED" />
  </prediction>
</evalitem>

